Moreover, in addition to activating NQO1 and HO-1, studies in MS have found that DMF increases the expression of GCLC and GPX [13], which indicates that the antioxidant pathway activated by DMF may be tissue-specific. The gene discussed is GCLC; the disease is myeloid sarcoma.